4

PRIMARY DOCUMENT

Company: LEXICON PHARMACEUTICALS, INC.
Filed: June 26, 2023
Period of Report: June 23, 2023
Accession Number: 0001127602-23-019405

View Document ↗ View on SEC.gov ↗